Wilmington Savings Fund Society FSB Acquires New Shares in Aspen Aerogels, Inc. (NYSE:ASPN)

Wilmington Savings Fund Society FSB bought a new stake in Aspen Aerogels, Inc. (NYSE:ASPN) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 18,000 shares of the construction company’s stock, valued at approximately $498,000.

Several other institutional investors have also recently bought and sold shares of ASPN. Point72 Hong Kong Ltd bought a new stake in shares of Aspen Aerogels during the 2nd quarter valued at approximately $84,000. nVerses Capital LLC bought a new stake in shares of Aspen Aerogels during the second quarter worth $95,000. Quent Capital LLC acquired a new position in shares of Aspen Aerogels during the third quarter worth $118,000. Point72 DIFC Ltd bought a new position in shares of Aspen Aerogels in the 2nd quarter valued at $121,000. Finally, Public Employees Retirement Association of Colorado acquired a new stake in shares of Aspen Aerogels during the 2nd quarter valued at $145,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Buying and Selling

In related news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 4.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ASPN. TD Cowen upped their target price on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. Roth Mkm lowered their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Friday, November 8th. Barclays cut their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 12th. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. Finally, Piper Sandler cut their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $28.70.

Aspen Aerogels Stock Down 1.6 %

Aspen Aerogels stock opened at $12.93 on Tuesday. The company has a market capitalization of $1.06 billion, a PE ratio of 1,293.00 and a beta of 2.11. Aspen Aerogels, Inc. has a 12-month low of $10.75 and a 12-month high of $33.15. The firm’s fifty day moving average is $17.13 and its 200 day moving average is $22.78. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.